These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30361124)

  • 41. New developments in nanoparticle-based vaccination.
    Riedmann EM
    Hum Vaccin Immunother; 2013 Dec; 9(12):2502. PubMed ID: 24716209
    [No Abstract]   [Full Text] [Related]  

  • 42. Closer look at vaccines.
    Kotz D
    US News World Rep; 2009 Feb; 146(1):22-7. PubMed ID: 19554938
    [No Abstract]   [Full Text] [Related]  

  • 43. [Policies and norms on obligatory vaccination].
    Rizzo G
    Ig Sanita Pubbl; 2003; 59(6):418-26. PubMed ID: 15116153
    [No Abstract]   [Full Text] [Related]  

  • 44. The "Fluad Case" in Italy: Could it have been dealt differently?
    Levi M; Sinisgalli E; Lorini C; Santomauro F; Chellini M; Bonanni P
    Hum Vaccin Immunother; 2017 Feb; 13(2):379-384. PubMed ID: 27924687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccine adjuvant safety: the elephant in the room.
    Petrovsky N
    Expert Rev Vaccines; 2013 Jul; 12(7):715-7. PubMed ID: 23885815
    [No Abstract]   [Full Text] [Related]  

  • 46. When an aluminium adjuvant is not an aluminium adjuvant used in human vaccination programmes.
    Exley C
    Vaccine; 2012 Mar; 30(12):2042. PubMed ID: 22041301
    [No Abstract]   [Full Text] [Related]  

  • 47. Dr. Jekyll or Mr. Hyde? (How) the Internet influences vaccination decisions: recent evidence and tentative guidelines for online vaccine communication.
    Betsch C; Sachse K
    Vaccine; 2012 May; 30(25):3723-6. PubMed ID: 22472790
    [No Abstract]   [Full Text] [Related]  

  • 48. Divergent policy responses to increasing vaccine scepticism in southern Europe.
    Kennedy J; Michailidou D
    Lancet Infect Dis; 2017 Sep; 17(9):900. PubMed ID: 28845793
    [No Abstract]   [Full Text] [Related]  

  • 49. Understanding the host-pathogen interaction saves lives: lessons from vaccines and vaccinations.
    Garon JR; Orenstein WA
    Curr Opin Immunol; 2015 Oct; 36():8-13. PubMed ID: 25974089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Health, public health, research, and participation. Considerations on the Italian ''Vaccination decree''].
    Micheli A; Barbone F; Biggeri A; Capocaccia R; Davoli M; Pirastu R; Richiardi L; Traversa G; Forastiere F
    Epidemiol Prev; 2017; 41(3-4):149-151. PubMed ID: 28929702
    [No Abstract]   [Full Text] [Related]  

  • 51. Ethical and policy issues in using vaccines to treat and prevent cocaine and nicotine dependence.
    Hall W; Gartner C
    Curr Opin Psychiatry; 2011 May; 24(3):191-6. PubMed ID: 21430537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The United States' Piecemeal Approach To Vaccine Policy.
    Bylander J
    Health Aff (Millwood); 2016 Feb; 35(2):195-8. PubMed ID: 26858369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Foreword.
    Etienne CF
    Vaccine; 2015 May; 33 Suppl 1():A1. PubMed ID: 25919148
    [No Abstract]   [Full Text] [Related]  

  • 54. Top health official resigns over Italy's "antiscientific" stance.
    Day M
    BMJ; 2019 Jan; 364():l50. PubMed ID: 30606706
    [No Abstract]   [Full Text] [Related]  

  • 55. Political will and vaccine legislation.
    Berkley S
    Vaccine; 2019 Aug; 37(35):4838-4839. PubMed ID: 30366808
    [No Abstract]   [Full Text] [Related]  

  • 56. Strategies and actions of multi-purpose health communication on vaccine preventable infectious diseases in order to increase vaccination coverage in the population: The ESCULAPIO project.
    Bechini A; Bonanni P; Lauri S; Tiscione E; Levi M; Prato R; Fortunato F; Martinelli D; Gasparini R; Panatto D; Amicizia D; Coppola RC; Pellizzari B; Tabacchi G; Costantino C; Vitale F; Iannazzo S; Boccalini S
    Hum Vaccin Immunother; 2017 Feb; 13(2):369-375. PubMed ID: 28215120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Allergic reactions to vaccines.
    Alves RR; Gaspar A; Ferreira MB
    Eur Ann Allergy Clin Immunol; 2007 Oct; 39(8):269-77. PubMed ID: 18237005
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gavi's balancing act: Accelerating access to vaccines while ensuring robust national decision-making for sustainable programmes.
    Sosler S; Kallenberg J; Johnson HL
    Vaccine; 2015 May; 33 Suppl 1():A4-5. PubMed ID: 25919172
    [No Abstract]   [Full Text] [Related]  

  • 59. The ProVac initiative and evolving decision support.
    Sanderson CF
    Vaccine; 2015 May; 33 Suppl 1():A8-10. PubMed ID: 25919181
    [No Abstract]   [Full Text] [Related]  

  • 60. Estimating the full public health value of vaccination.
    Gessner BD; Kaslow D; Louis J; Neuzil K; O'Brien KL; Picot V; Pang T; Parashar UD; Saadatian-Elahi M; Nelson CB
    Vaccine; 2017 Nov; 35(46):6255-6263. PubMed ID: 28986035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.